JPH11506730A - ペプチド/タンパク質懸濁配合物 - Google Patents
ペプチド/タンパク質懸濁配合物Info
- Publication number
- JPH11506730A JPH11506730A JP9500644A JP50064497A JPH11506730A JP H11506730 A JPH11506730 A JP H11506730A JP 9500644 A JP9500644 A JP 9500644A JP 50064497 A JP50064497 A JP 50064497A JP H11506730 A JPH11506730 A JP H11506730A
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- suspension
- agent
- viscosity
- beneficial agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.有益作用剤を固体粒子の形態で少なくとも5重量%含む懸濁液を含み、且 つ前記有益作用剤の粒径が0.3〜50ミクロンであり、前記懸濁液の粘度が長 期送達期間にわたって該懸濁配合物中における該作用剤の沈降を防止するのに十 分である、長期送達期間にわたって有益作用剤配合物を送達するデバイスにおい て用いるための有益作用剤配合物。 2.該粒径が、1〜10ミクロンである請求項1記載の配合物。 3.該粘度が、37℃で100〜100,000ポアズである請求項1記載の 配合物。 4.該長期送達期間が、少なくとも約1カ月である請求項1記載の配合物。 5.該懸濁液が、低分子量ポリオールと、増粘剤とを更に含む請求項1記載の 配合物。 6.該ポリオールが、200〜1000の分子量を有するポリエチレングリコ ールである請求項5記載の配合物。 7.該増粘剤が、ポピドンを含む請求項6記載の配合物。 8.該ポリオールが、200〜600の分子量を有するポリエチレングリコー ルである請求項5記載の配合物。 9.該増粘剤が、ポピドン又はヒドロキシプロピルセルロースを含む請求項8 記載の配合物。 10.該有益作用剤が、ヒトα−インターフェロンである請求項1記載の配合 物。 11.インターフェロンの濃度が、少なくとも1 x 109IUである請求項 10記載の配合物。 12.該有益作用剤が、感水化合物である請求項1記載の配合物。 13.請求項1記載の配合物を含む有益作用剤送達デバイス。 14.該デバイスを、動物の中に移植できるように適合させる請求項13記載 の有益作用剤送達デバイス。 15.(a)0.3〜50ミクロンの粒径を有する有益作用剤を0.5〜 70重量%;及び (b)37℃で100〜100,000ポアズの粘度によって特徴付けられる非 水懸濁液配合物、更に前記配合物は、200〜1000の分子量を有するポリエ チレングリコールと増粘剤とを含む を含む、長期送達期間にわたって持続調節送達するための組成物。 16.該増粘剤が、ポピドン又はヒドロキシプロピルセルロースを含む請求項 15記載の組成物。 17.請求項15記載の組成物を含む有益作用剤送達デバイス。 18.該デバイスを、動物の中に移植できるように適合させる請求項17記載 の有益作用剤送達デバイス。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/475,238 | 1995-06-07 | ||
US08/475,238 US5904935A (en) | 1995-06-07 | 1995-06-07 | Peptide/protein suspending formulations |
PCT/US1996/007377 WO1996040049A1 (en) | 1995-06-07 | 1996-05-22 | Peptide/protein suspended formulations |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008271657A Division JP2009057389A (ja) | 1995-06-07 | 2008-10-22 | ペプチド/タンパク質懸濁配合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11506730A true JPH11506730A (ja) | 1999-06-15 |
Family
ID=23886776
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9500644A Withdrawn JPH11506730A (ja) | 1995-06-07 | 1996-05-22 | ペプチド/タンパク質懸濁配合物 |
JP2008271657A Pending JP2009057389A (ja) | 1995-06-07 | 2008-10-22 | ペプチド/タンパク質懸濁配合物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008271657A Pending JP2009057389A (ja) | 1995-06-07 | 2008-10-22 | ペプチド/タンパク質懸濁配合物 |
Country Status (14)
Country | Link |
---|---|
US (2) | US5904935A (ja) |
EP (1) | EP0831773B1 (ja) |
JP (2) | JPH11506730A (ja) |
KR (1) | KR100460653B1 (ja) |
CN (1) | CN1138528C (ja) |
AT (1) | ATE187062T1 (ja) |
AU (1) | AU706318B2 (ja) |
CA (1) | CA2220871C (ja) |
DE (1) | DE69605417T2 (ja) |
DK (1) | DK0831773T3 (ja) |
ES (1) | ES2139360T3 (ja) |
FI (1) | FI119464B (ja) |
NZ (1) | NZ308843A (ja) |
WO (1) | WO1996040049A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002536315A (ja) * | 1999-02-08 | 2002-10-29 | アルザ・コーポレーション | 安定な非水性単相粘性ビヒクルおよびそのようなビヒクルを使用する配合物 |
JP2008533046A (ja) * | 2005-03-11 | 2008-08-21 | インデバス ファーマシューティカルズ、インク. | オクトレオチドの放出制御製剤 |
US7759312B2 (en) | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
US7960335B2 (en) | 2008-06-25 | 2011-06-14 | Endo Pharmaceuticals Solutions Inc. | Octreotide implant having a release agent and uses thereof |
US8071537B2 (en) | 2008-06-25 | 2011-12-06 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the sustained release of a polypeptide |
US9120249B2 (en) | 2007-04-27 | 2015-09-01 | Endo Pharmaceuticals Solutions Inc. | Implant device release agents and methods of using same |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6063910A (en) * | 1991-11-14 | 2000-05-16 | The Trustees Of Princeton University | Preparation of protein microparticles by supercritical fluid precipitation |
US6290991B1 (en) * | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
MY125870A (en) * | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system flow modulator apparatus and method |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
WO1999055310A1 (en) | 1998-04-27 | 1999-11-04 | Altus Biologics Inc. | Stabilized protein crystals, formulations containing them and methods of making them |
US8052982B2 (en) | 1998-07-20 | 2011-11-08 | Peptech Animal Health Pty Limited | Bioimplant formulation comprising lecithin and stearin |
AU751086B2 (en) * | 1998-09-09 | 2002-08-08 | Alza Corporation | Dosage form comprising liquid formulation |
US6194006B1 (en) | 1998-12-30 | 2001-02-27 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of microparticles having a selected release profile |
US7919109B2 (en) * | 1999-02-08 | 2011-04-05 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
AU2001238540A1 (en) | 2000-02-24 | 2001-09-03 | Monsanto Technology Llc | Non-aqueous injectable formulations for extended release of somatotropin |
ATE309822T1 (de) | 2000-04-19 | 2005-12-15 | Genentech Inc | Formulierungen mit verzögerter freisetzung enthaltend wachstumshormon |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US6264987B1 (en) | 2000-05-19 | 2001-07-24 | Alkermes Controlled Therapeutics Inc. Ii | Method for preparing microparticles having a selected polymer molecular weight |
US6495164B1 (en) | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
KR20030023878A (ko) | 2000-06-26 | 2003-03-20 | 몬산토 테크놀로지 엘엘씨 | 소마토트로핀의 지속적인 방출을 위한 계면활성제 함유비수성 제제들 |
US6664234B1 (en) * | 2000-06-30 | 2003-12-16 | Monsanto Technology Llc | Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin |
US6824822B2 (en) | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
US6471995B1 (en) | 2000-09-27 | 2002-10-29 | Alkermes Controlled Therapeutics, Inc. Ii | Apparatus and method for preparing microparticles using liquid-liquid extraction |
US20020114843A1 (en) | 2000-12-27 | 2002-08-22 | Ramstack J. Michael | Preparation of microparticles having improved flowability |
EP1345968A2 (en) * | 2000-12-28 | 2003-09-24 | Altus Biologics Inc. | Crystals of whole antibodies and fragments thereof and methods for making and using them |
WO2002067991A1 (en) * | 2001-02-23 | 2002-09-06 | Genentech, Inc. | Erodible polymers for injection |
PT1397155E (pt) * | 2001-06-21 | 2015-12-07 | Genentech Inc | Formulação de libertação sustentada |
JP2005500304A (ja) * | 2001-06-21 | 2005-01-06 | アルタス バイオロジックス インコーポレイテッド | 球状タンパク質粒子およびそれらの作製方法および使用方法 |
EP1458360B1 (en) | 2001-12-19 | 2011-05-11 | Novartis AG | Pulmonary delivery of aminoglycosides |
EP1536767B1 (en) * | 2002-06-17 | 2007-08-08 | Alza Corporation | Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle |
WO2004056338A2 (en) * | 2002-12-19 | 2004-07-08 | Alza Corporation | Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
US7731947B2 (en) * | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
KR20050120767A (ko) * | 2003-03-31 | 2005-12-23 | 알자 코포레이션 | 삼투성 전달 시스템 및 삼투성 전달 시스템의 기동 시간감소 방법 |
BRPI0408862A (pt) * | 2003-03-31 | 2006-04-11 | Alza Corp | bomba osmótica com dispositivo para dissipar pressão interna |
CA2530136C (en) | 2003-06-26 | 2012-10-16 | Control Delivery Systems, Inc. | In-situ gelling drug delivery system |
WO2005000268A2 (en) * | 2003-06-26 | 2005-01-06 | Control Delivery Systems, Inc. | Bioerodible sustained release drug delivery systems |
AU2004269196B2 (en) | 2003-09-03 | 2010-03-04 | Shmuel Bukshpan | Methods and apparatus for rapid crystallization of biomolecules |
JP2007509703A (ja) * | 2003-10-31 | 2007-04-19 | アルザ・コーポレーシヨン | 自己保持性、迅速スタート膜プラグを有する浸透式ポンプ |
WO2005046639A2 (en) * | 2003-11-06 | 2005-05-26 | Alza Corporation | Modular imbibition rate reducer for use with implantable osmotic pump |
JP5030292B2 (ja) | 2004-04-15 | 2012-09-19 | アミリン・ファーマシューティカルズ,インコーポレイテッド | ポリマーを基にした持続放出性装置 |
US20050266087A1 (en) * | 2004-05-25 | 2005-12-01 | Gunjan Junnarkar | Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium |
US20060029551A1 (en) * | 2004-08-05 | 2006-02-09 | Kui Liu | Stable particle formulations of erythropoietin receptor agonists |
US7772182B2 (en) * | 2004-08-05 | 2010-08-10 | Alza Corporation | Stable suspension formulations of erythropoietin receptor agonists |
US20060045891A1 (en) * | 2004-08-24 | 2006-03-02 | Lovalenti Phillip M | Density-matched suspension vehicles and pharmaceutical suspensions |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
JP2008528698A (ja) * | 2005-02-03 | 2008-07-31 | インターシア セラピューティクス,インコーポレイティド | 埋め込み可能なインターフェロン含有デバイス |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
US7959938B2 (en) * | 2005-03-15 | 2011-06-14 | Intarcia Therapeutics, Inc. | Polyoxaester suspending vehicles for use with implantable delivery systems |
MX2008014870A (es) | 2006-05-30 | 2009-02-12 | Intarcia Therapeutics Inc | Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas. |
NZ573174A (en) * | 2006-06-01 | 2012-01-12 | Msd Consumer Care Inc | Sustained release pharmaceutical dosage form containing phenylephrine |
EP2359808B1 (en) * | 2006-08-09 | 2013-05-22 | Intarcia Therapeutics, Inc | Osmotic delivery systems and piston assemblies |
CN105688191A (zh) | 2007-04-23 | 2016-06-22 | 精达制药公司 | 促胰岛素释放肽的混悬制剂及其应用 |
WO2008132224A2 (en) | 2007-04-30 | 2008-11-06 | Novo Nordisk A/S | Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
CA2691531C (en) | 2007-06-22 | 2016-11-01 | Board Of Regents,The University Of Texas System | Formation of stable submicron peptide or protein particles by thin film freezing |
WO2009102467A2 (en) | 2008-02-13 | 2009-08-20 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
LT2328601T (lt) | 2008-08-15 | 2020-04-27 | Ironwood Pharmaceuticals, Inc. | Linaklotidą turinčios vaisto formos, skirtos vartoti per burną |
CA2738715C (en) * | 2008-10-15 | 2013-07-16 | Intarcia Therapeutics, Inc. | Highly concentrated drug particles, formulations, suspensions and uses thereof |
CA2743789C (en) | 2008-11-16 | 2017-10-31 | Board Of Regents, The Univesity Of Texas System | Low viscosity highly concentrated suspensions |
EP3466438A1 (en) | 2009-08-03 | 2019-04-10 | Incube Labs, Llc | Swallowable capsule and method for stimulating incretin production within the intestinal tract |
CA2770077A1 (en) | 2009-08-06 | 2011-02-10 | Ironwood Pharmaceuticals, Inc. | Formulations comprising linaclotide |
MX352878B (es) | 2009-09-28 | 2017-12-13 | Intarcia Therapeutics Inc | Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco. |
US8721620B2 (en) | 2009-12-24 | 2014-05-13 | Rani Therapeutics, Llc | Swallowable drug delivery device and methods of drug delivery |
MX340234B (es) | 2010-02-17 | 2016-07-01 | Ironwood Pharmaceuticals Inc | Tratamiento para transtornos gastrointestinales. |
US9072668B2 (en) | 2010-03-09 | 2015-07-07 | Janssen Biotech, Inc. | Non-aqueous high concentration reduced viscosity suspension formulations of antibodies |
CA2808091C (en) | 2010-08-11 | 2019-05-21 | Ironwood Pharmaceuticals, Inc. | Stable formulations of linaclotide |
US8980822B2 (en) | 2010-12-23 | 2015-03-17 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US10639272B2 (en) | 2010-12-23 | 2020-05-05 | Rani Therapeutics, Llc | Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device |
US8809271B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
US8969293B2 (en) | 2010-12-23 | 2015-03-03 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9629799B2 (en) | 2010-12-23 | 2017-04-25 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9861683B2 (en) | 2010-12-23 | 2018-01-09 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9149617B2 (en) | 2010-12-23 | 2015-10-06 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9284367B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9402807B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8846040B2 (en) | 2010-12-23 | 2014-09-30 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8764733B2 (en) * | 2010-12-23 | 2014-07-01 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9283179B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US20120208755A1 (en) * | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
CA2846230A1 (en) | 2011-08-17 | 2013-02-21 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
JP6993235B2 (ja) | 2015-06-03 | 2022-01-13 | インターシア セラピューティクス,インコーポレイティド | インプラントの設置及び撤去システム |
EP3458084B1 (en) | 2016-05-16 | 2020-04-01 | Intarcia Therapeutics, Inc | Glucagon-receptor selective polypeptides and methods of use thereof |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
KR20190104039A (ko) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법 |
USD933219S1 (en) | 2018-07-13 | 2021-10-12 | Intarcia Therapeutics, Inc. | Implant removal tool and assembly |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3732865A (en) * | 1971-01-13 | 1973-05-15 | Alza Corp | Osmotic dispenser |
US3833725A (en) * | 1972-12-08 | 1974-09-03 | Syntex Corp | Dialkylated glycol compositions and medicament preparations containing same |
US4036954A (en) * | 1973-11-02 | 1977-07-19 | Yamanouchi Pharmaceutical Co., Ltd. | Stable prostaglandin E group-containing formulation |
US4180560A (en) * | 1976-10-26 | 1979-12-25 | Syntex Corporation | Inert core implant pellet |
US4215691A (en) * | 1978-10-11 | 1980-08-05 | Alza Corporation | Vaginal contraceptive system made from block copolymer |
US4237885A (en) * | 1978-10-23 | 1980-12-09 | Alza Corporation | Delivery system with mated members for storing and releasing a plurality of beneficial agents |
US4389414A (en) * | 1981-05-11 | 1983-06-21 | Syntex (U.S.A.) Inc. | Prostaglandin compositions |
US4507281A (en) * | 1981-10-13 | 1985-03-26 | Exovir, Inc. | Interferon-containing compositions |
US4475916A (en) * | 1982-03-18 | 1984-10-09 | Merck & Co., Inc. | Osmotic drug delivery system |
DE3378250D1 (en) * | 1982-04-22 | 1988-11-24 | Ici Plc | Continuous release formulations |
US4483849A (en) * | 1983-01-07 | 1984-11-20 | Carter William A | Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product |
AU2698684A (en) * | 1983-07-01 | 1985-02-07 | Battelle Memorial Institute | Polypeptide biodegradable et son utilisation pour le relargage progressif de medicaments |
US4855134A (en) * | 1983-10-14 | 1989-08-08 | Sumitomo Pharmaceuticals Company, Limited | Sustained-release preparation |
GB2155889B (en) * | 1984-03-21 | 1988-03-02 | Alza Corp | Dispenser-capsule |
US5032572A (en) * | 1984-07-18 | 1991-07-16 | Medical College Of Ohio | Polymers containing cross-linked azo bonds, which polymers are useful for releasing therapeutic agents into the lower gastrointestinal tract |
US4847079A (en) * | 1985-07-29 | 1989-07-11 | Schering Corporation | Biologically stable interferon compositions comprising thimerosal |
GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
US4853218A (en) * | 1987-02-24 | 1989-08-01 | Schering Corporation | Zinc-protamine-alpha interferon complex |
JPS63281299A (ja) * | 1987-05-13 | 1988-11-17 | Hitachi Ltd | 連想メモリ装置 |
EP0294160A1 (en) * | 1987-06-02 | 1988-12-07 | Schering Corporation | Treatment of chronic type b hepatitis with a combination of recombinant human alpha and gamma interferons |
US4871538A (en) * | 1987-07-13 | 1989-10-03 | Schering Corporation | Insoluble copper-alpha interferon complex |
IT1222734B (it) * | 1987-09-25 | 1990-09-12 | Scalvo S P A | Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina |
US4855141A (en) * | 1988-03-25 | 1989-08-08 | Alza Corporation | Device comprising means for protecting and dispensing fluid sensitive medicament |
HU201567B (en) * | 1988-07-21 | 1990-11-28 | Gyogyszerkutato Intezet | Process for production of intravenous medical compositions containing cyclosphorin |
US5342625A (en) * | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
US5034229A (en) * | 1988-12-13 | 1991-07-23 | Alza Corporation | Dispenser for increasing feed conversion of hog |
EP0374120A3 (en) * | 1988-12-13 | 1991-07-31 | Monsanto Company | Comosition for controlled release of polypeptides |
US5057318A (en) * | 1988-12-13 | 1991-10-15 | Alza Corporation | Delivery system for beneficial agent over a broad range of rates |
US5110596A (en) * | 1988-12-13 | 1992-05-05 | Alza Corporation | Delivery system comprising means for delivering agent to livestock |
IT8920486A0 (it) * | 1989-05-12 | 1989-05-12 | Isf Spa | Composizioni farmaceutiche. |
JP2514249B2 (ja) * | 1989-05-23 | 1996-07-10 | 帝人株式会社 | 安定化されたカルシトニン類医薬組成物 |
US5100392A (en) * | 1989-12-08 | 1992-03-31 | Biosynthesis, Inc. | Implantable device for administration of drugs or other liquid solutions |
IT1242642B (it) * | 1990-04-17 | 1994-05-16 | Alfa Wassermann Spa | Formulazioni iniettabili contenenti naproxen sale sodico. |
FR2663223B1 (fr) * | 1990-06-14 | 1994-12-02 | Af Aplicaciones Far Lab | Forme galenique parenterale. |
US5137727A (en) * | 1991-06-12 | 1992-08-11 | Alza Corporation | Delivery device providing beneficial agent stability |
US5236707A (en) * | 1991-11-08 | 1993-08-17 | Dallas Biotherapeutics, Inc. | Stabilization of human interferon |
JP3730667B2 (ja) * | 1991-12-27 | 2006-01-05 | 武田薬品工業株式会社 | 注射用組成物 |
US5223265A (en) * | 1992-01-10 | 1993-06-29 | Alza Corporation | Osmotic device with delayed activation of drug delivery |
US5221278A (en) * | 1992-03-12 | 1993-06-22 | Alza Corporation | Osmotically driven delivery device with expandable orifice for pulsatile delivery effect |
US5614487A (en) * | 1993-05-28 | 1997-03-25 | Genentech, Inc. | Sustained release pharmaceutical composition |
WO1995010989A1 (en) * | 1993-10-19 | 1995-04-27 | Scimed Life Systems, Inc. | Intravascular stent pump |
JP3901727B2 (ja) * | 1994-06-13 | 2007-04-04 | アルザ コーポレイション | 液状組成物中の医薬を投与するための剤型 |
WO1999008832A1 (de) * | 1997-08-20 | 1999-02-25 | Mikron Sa Agno | Vorrichtung zum bewegen und positionieren eines gegenstandes in einer ebene |
-
1995
- 1995-06-07 US US08/475,238 patent/US5904935A/en not_active Expired - Lifetime
-
1996
- 1996-05-22 CN CNB961944943A patent/CN1138528C/zh not_active Expired - Fee Related
- 1996-05-22 JP JP9500644A patent/JPH11506730A/ja not_active Withdrawn
- 1996-05-22 AT AT96920358T patent/ATE187062T1/de not_active IP Right Cessation
- 1996-05-22 EP EP96920358A patent/EP0831773B1/en not_active Expired - Lifetime
- 1996-05-22 NZ NZ308843A patent/NZ308843A/xx not_active IP Right Cessation
- 1996-05-22 KR KR1019970708967A patent/KR100460653B1/ko not_active IP Right Cessation
- 1996-05-22 AU AU58694/96A patent/AU706318B2/en not_active Ceased
- 1996-05-22 CA CA2220871A patent/CA2220871C/en not_active Expired - Fee Related
- 1996-05-22 DE DE69605417T patent/DE69605417T2/de not_active Expired - Lifetime
- 1996-05-22 DK DK96920358T patent/DK0831773T3/da active
- 1996-05-22 ES ES96920358T patent/ES2139360T3/es not_active Expired - Lifetime
- 1996-05-22 WO PCT/US1996/007377 patent/WO1996040049A1/en active IP Right Grant
-
1997
- 1997-12-05 FI FI974429A patent/FI119464B/fi active IP Right Grant
-
1999
- 1999-01-28 US US09/238,159 patent/US5972370A/en not_active Expired - Lifetime
-
2008
- 2008-10-22 JP JP2008271657A patent/JP2009057389A/ja active Pending
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002536315A (ja) * | 1999-02-08 | 2002-10-29 | アルザ・コーポレーション | 安定な非水性単相粘性ビヒクルおよびそのようなビヒクルを使用する配合物 |
JP2008533046A (ja) * | 2005-03-11 | 2008-08-21 | インデバス ファーマシューティカルズ、インク. | オクトレオチドの放出制御製剤 |
US7759312B2 (en) | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
US7803773B2 (en) | 2005-03-11 | 2010-09-28 | Endo Pharmaceuticals Solutions Inc. | Controlled release formulations of octreotide |
US9120249B2 (en) | 2007-04-27 | 2015-09-01 | Endo Pharmaceuticals Solutions Inc. | Implant device release agents and methods of using same |
US7960335B2 (en) | 2008-06-25 | 2011-06-14 | Endo Pharmaceuticals Solutions Inc. | Octreotide implant having a release agent and uses thereof |
US8071537B2 (en) | 2008-06-25 | 2011-12-06 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the sustained release of a polypeptide |
US8383577B2 (en) | 2008-06-25 | 2013-02-26 | Endo Pharmaceuticals Solutions, Inc. | Octreotide implant having a release agent |
US8475820B2 (en) | 2008-06-25 | 2013-07-02 | Endo Pharmaceuticals Solutions Inc. | Method of manufacturing an implantable device |
US9072786B2 (en) | 2008-06-25 | 2015-07-07 | Endo Pharmaceuticals Solutions Inc. | Method of manufacturing an implantable device |
Also Published As
Publication number | Publication date |
---|---|
AU706318B2 (en) | 1999-06-17 |
KR100460653B1 (ko) | 2005-08-05 |
JP2009057389A (ja) | 2009-03-19 |
CN1138528C (zh) | 2004-02-18 |
CA2220871A1 (en) | 1996-12-19 |
AU5869496A (en) | 1996-12-30 |
ES2139360T3 (es) | 2000-02-01 |
EP0831773A1 (en) | 1998-04-01 |
CA2220871C (en) | 2011-02-08 |
DK0831773T3 (da) | 2000-05-08 |
CN1187119A (zh) | 1998-07-08 |
FI974429A (fi) | 1997-12-05 |
ATE187062T1 (de) | 1999-12-15 |
DE69605417T2 (de) | 2000-03-23 |
WO1996040049A1 (en) | 1996-12-19 |
DE69605417D1 (de) | 2000-01-05 |
KR19990022486A (ko) | 1999-03-25 |
EP0831773B1 (en) | 1999-12-01 |
US5904935A (en) | 1999-05-18 |
FI974429A0 (fi) | 1997-12-05 |
US5972370A (en) | 1999-10-26 |
FI119464B (fi) | 2008-11-28 |
NZ308843A (en) | 2000-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11506730A (ja) | ペプチド/タンパク質懸濁配合物 | |
AU2010212478B2 (en) | Non-aqueous single phase vehicles and formulations utilizing such vehicles | |
AU2005247439B2 (en) | A biomolecule-containing formulation of increased stability | |
JP4361710B2 (ja) | 徐放製剤 | |
US20170119855A1 (en) | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | |
KR20050088196A (ko) | 안정한 비수성 단일 상 겔 및 이식가능한 장치로부터전달하기 위한 이의 제형 | |
US20110160708A1 (en) | Stable non-aqueous single phase viscous vehicles and formulations utlizing such vehicles | |
CN1230108A (zh) | 用于持续释放蛋白质药物的温敏凝胶 | |
WO2004073729A1 (ja) | 薬物の経鼻投与用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061031 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070130 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070402 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070501 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080624 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20081022 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081224 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20111026 |